Gadolinium Lawyers, Attorneys and Lawsuits

Gadolinium Lawyers

The gadolinium lawyers at Morgan & Morgan are warning consumers of serious risks associated with the MRI/MRA contrast dye Gadolinium. Gadolinium is a chemical element that is often used in MRI (Magnetic Resonance Imaging), MRA (Magnetic Resonance Angiogram), X-Ray, and other imaging technology as a contrast agent. Contrast dyes are injected into the body of a patient being imaged, in order to enhance the quality of the image. However, Nephrogenic Systemic Fibrosis (NSF), a serious and potentially fatal disease has been linked to the use of Gadolinium. If you have been diagnosed with NSF, contact our experienced gadolinium lawyers to have your case reviewed for free.

Gadolinium Exposure Dangers

FDA Approved Use: MRI Contrast Agent
Generic Name: Gadodiamide
Warnings:
- FDA Public Health Advisory, June 2006
- FDA Public Health Advisory, December 2006
- FDA Black Box Warning, May 2007
Side Effects: Linked to Nephrogenic Systemic Fibrosis (NSF) and Nephrogenic Fibrosing Dermopathy (NFD)
Risk Factors: Pre-existing kidney or renal conditions

Contact our gadolinium lawyers today if you have been injured by an MRI Contrast-Dye Injection.

In 2007, the Food and Drug Administration (FDA) issued its strongest warning for gadolinium based contrast agents used in MRIs and MRAs (the "Black Box Warning"). The medical product has been associated with a life-threatening illness in patients with existing kidney conditions. MRI or MRA patients with severe kidney (renal) problems who are injected with a Gadolinium containing contrast agent are at risk of contracting Nephrogenic Systemic Fibrosis, also called Nephrogenic Fibrosing Dermopathy (NFD). There is no consistently effective treatment to combat this condition. Gadolinium lawyers are working to defend the rights of individuals who have been harmed by gadolinium and hold the gadolinium dye manufacturers responsible for their failure to warn consumers about its risks.

Gadolinium has been approved by the FDA as a contrast agent for MRI's only (not MRA's), and is marketed under the following brand names in the United States:

Magnevist (gadopentetate dimeglumine) manufactured by Bayer Schering Pharma

Ominiscan (gadodiamide) manufactured by GE Healthcare

OptiMARK (gadoversetamide) manufactured by Mallinckrodt, Inc.

MultiHance (gadobenate dimeglumine) manufactured by Bracco Diagnostics, Inc.

ProHance (gadoteridol) manufactured by Bracco Diagnostics, Inc.

Morgan & Morgan's gadolinium attorneys want consumers to be aware that any of these gadolinium contrast dye products could expose you to the toxic substance and potentially cause Nephrogenic Systemic Fibrosis. Symptoms of NSF/NFD include swelling, thickening and hardening skin, in the extremities, and occasionally in the torso/trunk area. Symptoms usually appear within 2 to 12 weeks following the Gadolinium injection. Skin thickening due to NSF or NFD often inhibits joint flexion/extension and causes painful contractures. Other symptoms of excessive gadolinium exposure include:

Harm to connective tissues of the body

Difficulty moving and in extreme cases, an inability to walk or extend joints

Hardening of internal organs

Muscle weakness

Reddened/darkened skin patches, papules, or plaque

Burning or itching of the skin

Yellow raised spots on the whites of the eyes

Pain in hip bones or ribs

Unfortunately, Gadolinium is still on the market and is used by doctors. If you or a loved one experiences any of these symptoms, following the injection of a Gadolinium containing contrast agent in the course of an MRI, MRA, or X-Ray, you should speak with your doctor immediately. A gadolinium lawyer may be able to help you recover compensation for injuries and damages caused by gadolinium. Fill out the form on this page to find out if you are eligble to participate in a Gadolinium lawsuit.

If you are suffering from NSF due to Gadolinium exposure, contact Morgan and Morgan's Gadolinium Lawyers today to ensure that your rights are protected.

About Morgan & Morgan

ForThePeople.com